Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2020 Sep 23

PMID 32961987

Citations 23

Authors

Wamidh H Talib

Ahmad Riyad Alsayed

Faten Farhan

Lina T Al Kury

Affiliations

Soon will be listed here.

Abstract

Resveratrol (3,4',5 trihydroxystilbene) is a naturally occurring non-flavonoid polyphenol. It has various pharmacological effects including antioxidant, anti-diabetic, anti-inflammatory and anti-cancer. Many studies have given special attention to different aspects of resveratrol anti-cancer properties and proved its high efficiency in targeting multiple cancer hallmarks. Tumor microenvironment has a critical role in cancer development and progression. Tumor cells coordinate with a cast of normal cells to aid the malignant behavior of cancer. Many cancer supporting players were detected in tumor microenvironment. These players include blood and lymphatic vessels, infiltrating immune cells, stromal fibroblasts and the extracellular matrix. Targeting tumor microenvironment components is a promising strategy in cancer therapy. Resveratrol with its diverse biological activities has the capacity to target tumor microenvironment by manipulating the function of many components surrounding cancer cells. This review summarizes the targets of resveratrol in tumor microenvironment and the mechanisms involved in this targeting. Studies discussed in this review will participate in building a solid ground for researchers to have more insight into the mechanism of action of resveratrol in tumor microenvironment.

Citing Articles

Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases.

Abolfazli S, Karav S, Johnston T, Sahebkar A Pharmacol Rep. 2025; .

PMID: 39832074 DOI: 10.1007/s43440-025-00694-w.

The Potential Application of Resveratrol and Its Derivatives in Central Nervous System Tumors.

Nowacka A, Sniegocka M, Smuczynski W, Liss S, Ziolkowska E, Bozilow D Int J Mol Sci. 2025; 25(24.

PMID: 39769099 PMC: 11728356. DOI: 10.3390/ijms252413338.

Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.

Soto-Sanchez J, Garza-Trevino G Pharmaceutics. 2024; 16(10).

PMID: 39458571 PMC: 11510106. DOI: 10.3390/pharmaceutics16101239.

Resveratrol and Its Natural Analogs Mitigate Immune Dysregulation and Oxidative Imbalance in the Endometriosis Niche Simulated in a Co-Culture System of Endometriotic Cells and Macrophages.

Golabek-Grenda A, Juzwa W, Kaczmarek M, Olejnik A Nutrients. 2024; 16(20).

PMID: 39458478 PMC: 11510005. DOI: 10.3390/nu16203483.

Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers.

Djaldetti M Oncol Res. 2024; 32(9):1389-1399.

PMID: 39220125 PMC: 11361903. DOI: 10.32604/or.2024.049745.

References

Zamora-Ros R, Urpi-Sarda M, Lamuela-Raventos R, Martinez-Gonzalez M, Salas-Salvado J, Aros F . High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients. Pharmacol Res. 2012; 65(6):615-20. DOI: 10.1016/j.phrs.2012.03.009. View

Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A . Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med. 2015; 7(298):298ra117. PMC: 4827609. DOI: 10.1126/scitranslmed.aaa7619. View

Zhu W, Qin W, Hewett J, Sauter E . Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids. Int J Cancer. 2009; 126(2):474-82. PMC: 3398695. DOI: 10.1002/ijc.24728. View

Hinshaw D, Shevde L . The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019; 79(18):4557-4566. PMC: 6744958. DOI: 10.1158/0008-5472.CAN-18-3962. View

Lin Z, Zheng L, Zhang H, Tsang S, Bian Z . Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells. BMC Complement Altern Med. 2015; 15:259. PMC: 4520255. DOI: 10.1186/s12906-015-0789-y. View

Wenzel E, Somoza V . Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res. 2005; 49(5):472-81. DOI: 10.1002/mnfr.200500010. View

Talib W, Al-Hadid S, Ali M, Al-Yasari I, Ali M . Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action. Breast Cancer (Dove Med Press). 2018; 10:207-217. PMC: 6276637. DOI: 10.2147/BCTT.S167812. View

Guo Y, Xu F, Lu T, Duan Z, Zhang Z . Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012; 38(7):904-10. DOI: 10.1016/j.ctrv.2012.04.007. View

Chun J, Nadiminty N, Dutt S, Lou W, Yang J, Kung H . Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res. 2009; 15(15):4815-22. PMC: 3041150. DOI: 10.1158/1078-0432.CCR-09-0640. View

10.

Ozdemir B, Pentcheva-Hoang T, Carstens J, Zheng X, Wu C, Simpson T . Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014; 25(6):719-34. PMC: 4180632. DOI: 10.1016/j.ccr.2014.04.005. View

11.

Vinay D, Ryan E, Pawelec G, Talib W, Stagg J, Elkord E . Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015; 35 Suppl:S185-S198. DOI: 10.1016/j.semcancer.2015.03.004. View

12.

Juan M, Vinardell M, Planas J . The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr. 2002; 132(2):257-60. DOI: 10.1093/jn/132.2.257. View

13.

Lee M, Kundu J, Keum Y, Cho Y, Surh Y, Choi B . Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells. Biomol Ther (Seoul). 2014; 22(5):426-30. PMC: 4201228. DOI: 10.4062/biomolther.2014.061. View

14.

Macip S, Igarashi M, Berggren P, Yu J, Lee S, Aaronson S . Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol. 2003; 23(23):8576-85. PMC: 262651. DOI: 10.1128/MCB.23.23.8576-8585.2003. View

15.

Takahashi H, Shibuya M . The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond). 2005; 109(3):227-41. DOI: 10.1042/CS20040370. View

16.

Hadi S, Asad S, Singh S, Ahmad A . Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life. 2001; 50(3):167-71. DOI: 10.1080/152165400300001471. View

17.

Wightman E, Reay J, Haskell C, Williamson G, Dew T, Kennedy D . Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. Br J Nutr. 2014; 112(2):203-13. DOI: 10.1017/S0007114514000737. View

18.

Chow H, Garland L, Heckman-Stoddard B, Hsu C, Butler V, Cordova C . A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J Transl Med. 2014; 12:223. PMC: 4243716. DOI: 10.1186/s12967-014-0223-0. View

19.

Qian B, Pollard J . Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141(1):39-51. PMC: 4994190. DOI: 10.1016/j.cell.2010.03.014. View

20.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View